Effects of Tropisetron on Stroke in Rats
Author Information
Author(s): Eduardo Candelario-Jalil, Eduardo Muñoz, Bernd L. Fiebich
Primary Institution: University of Freiburg Medical School
Hypothesis
Does the 5-HT3 receptor antagonist tropisetron have a neuroprotective effect against ischemic stroke in rats?
Conclusion
Tropisetron worsens neurological deficits and increases mortality in rats after ischemic stroke without reducing infarct size.
Supporting Evidence
- Tropisetron did not reduce infarct volume in treated rats.
- Rats receiving 10 mg/kg of tropisetron had a mortality rate of 55.5%.
- Neurological deficits increased significantly in rats treated with tropisetron.
Takeaway
This study found that a drug called tropisetron, which is supposed to help with brain injuries, actually made things worse for rats that had a stroke.
Methodology
Rats were given two doses of tropisetron or a vehicle before inducing stroke, and outcomes were measured 24 hours later.
Potential Biases
Potential publication bias against negative results in preclinical studies.
Limitations
The study was conducted only in rats, and the effects in humans may differ.
Participant Demographics
Male Sprague-Dawley rats weighing 280–320 g.
Statistical Information
P-Value
0.0089
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website